en

PRODUCT DETAIL

INZOLFI 0,25 mg tvrdé kapsuly

Code 2683E
MA number 59/0010/23-S
Product Form: cps dur 98x0,25 mg (blis.PVC/PVDC/Al v puzdre)
MA Status: R - Valid Marketing Authorisation
Type of procedure: Decentralised
Therapeutic Class: 59 - IMMUNOPRAEPARATA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 Immunosuppressants
L04A Immunosuppressants
L04AA Selective immunosuppressants
L04AA27 Fingolimod
Shelf life: 24
Container: blister PVC/PVDC/Al
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 25.01.2023
Validity: 25.01.2028
Pediatric indication: Yes
Pediatric posology: Yes
Pediatric warnings: Yes
SPC: SPC_INZOLFI_025mg tvrdé kapsuly 01_2023.pdf  
PIL: PIL_INZOLFI_0,25mg tvrdé kapsuly 01_2023.pdf  
Safety feature Yes
Data update: 31.01.2023
eu-flag.png sk-flag.png